Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Beam Therapeutics Inc (BEAM)

Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,027,919
  • Shares Outstanding, K 82,806
  • Annual Sales, $ 377,710 K
  • Annual Income, $ -132,530 K
  • EBIT $ -183 M
  • EBITDA $ -192 M
  • 60-Month Beta 1.86
  • Price/Sales 5.54
  • Price/Cash Flow N/A
  • Price/Book 2.65

Options Overview Details

View History
  • Implied Volatility 98.65% ( +19.34%)
  • Historical Volatility 80.96%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 98.65% on 11/21/24
  • IV Low 35.30% on 05/31/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 916
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 13,568
  • Open Int (30-Day) 12,445

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.16
  • Number of Estimates 8
  • High Estimate -0.88
  • Low Estimate -1.37
  • Prior Year 1.73
  • Growth Rate Est. (year over year) -167.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.14 +15.07%
on 10/24/24
32.29 -24.68%
on 11/11/24
+1.17 (+5.05%)
since 10/21/24
3-Month
21.14 +15.07%
on 10/24/24
32.29 -24.68%
on 11/11/24
-1.17 (-4.59%)
since 08/21/24
52-Week
20.84 +16.70%
on 04/25/24
49.50 -50.87%
on 02/27/24
-3.63 (-12.99%)
since 11/21/23

Most Recent Stories

More News
Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference

BEAM : 24.25 (-0.98%)
Beam Therapeutics' Q3 Earnings & Revenues Fall Shy of Estimates

Beam Therapeutics Inc. BEAM incurred a loss of $1.17 per share in the third quarter of 2024, wider than the Zacks Consensus Estimate of a loss of $1.13. The company had recorded a loss of $1.22 per share...

BEAM : 24.25 (-0.98%)
FOLD : 9.52 (-0.73%)
AVIR : 3.18 (+0.63%)
CRSP : 46.44 (-1.74%)
Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (ASH) Annual Meeting

BEAM : 24.25 (-0.98%)
Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs

BEAM : 24.25 (-0.98%)
Beam Therapeutics to Hold Conference Call to Discuss Third Quarter 2024 Financial Results and Abstracts Accepted for Presentation at ASH Annual Meeting

BEAM : 24.25 (-0.98%)
3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference...

ARKK : 55.39 (+0.20%)
NTLA : 14.03 (+6.94%)
PRME : 2.92 (-2.34%)
BEAM : 24.25 (-0.98%)
XBI : 93.64 (-0.39%)
WFC : 74.63 (+1.43%)
VKTX : 50.94 (-1.14%)
CRSP : 46.44 (-1.74%)
ABBV : 167.65 (-0.07%)
AMGN : 286.49 (-0.48%)
BMY : 58.17 (+0.50%)
GILD : 88.37 (-0.29%)
Why Beam Therapeutics Stock Zoomed 17% Higher Today

JPMorgan Chase becomes the latest institution in the company's bull pen.

VERV : 4.54 (-0.22%)
LLY : 740.69 (-1.69%)
BEAM : 24.25 (-0.98%)
JPM : 243.46 (+1.11%)
Stocks Set to Open Mixed as Investors Await Fed Meeting and Big Tech Earnings

March S&P 500 E-Mini futures (ESH24) are down -0.04%, and March Nasdaq 100 E-Mini futures (NQH24) are up +0.11% this morning as market participants braced for the Federal Reserve’s first monetary policy...

ESH24 : 5,101.67s (-1.01%)
NQH24 : 17,854.75s (-0.94%)
INTC : 24.17 (+0.67%)
KLAC : 626.57 (+1.58%)
WDC : 65.06 (+1.91%)
AXP : 288.71 (+0.35%)
MSFT : 415.94 (+0.31%)
GOOGL : 168.45 (-4.28%)
AAPL : 227.66 (-0.59%)
AMZN : 201.13 (-0.86%)
META : 559.08 (-1.14%)
AMD : 137.62 (+0.01%)
3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street

Analysts have high hopes for these three innovation companies in 2024.

BEAM : 24.25 (-0.98%)
EWTX : 32.05 (+0.31%)
GLUE : 8.40 (+0.48%)
4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024

Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run.

ARKK : 55.39 (+0.20%)
ARKW : 107.11 (+1.18%)
GH : 31.00 (+1.04%)
ARKG : 23.21 (-0.64%)
BEAM : 24.25 (-0.98%)
DNA : 6.40 (+0.63%)
NTLA : 14.03 (+6.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 26.92
2nd Resistance Point 26.40
1st Resistance Point 25.44
Last Price 24.25
1st Support Level 23.96
2nd Support Level 23.44
3rd Support Level 22.48

See More

52-Week High 49.50
Fibonacci 61.8% 38.55
Fibonacci 50% 35.17
Fibonacci 38.2% 31.79
Last Price 24.25
52-Week Low 20.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar